Test All for Hepatitis B Virus: Link to Care and Treatment if Quantitative DNA Positive, Vaccinate if Susceptible

Katerina Roma; Zahra Dossaji; Lubaba Haque; Tooba Laeeq; Robert G Gish; Carol Brosgart

doi:10.1016/j.cld.2023.05.009

Test All for Hepatitis B Virus: Link to Care and Treatment if Quantitative DNA Positive, Vaccinate if Susceptible

Clin Liver Dis. 2023 Nov;27(4):997-1022. doi: 10.1016/j.cld.2023.05.009. Epub 2023 Jul 7.

Authors

Katerina Roma¹, Zahra Dossaji², Lubaba Haque², Tooba Laeeq², Robert G Gish³, Carol Brosgart⁴

Affiliations

¹ Internal Medicine, Kirk Kerkorian School of Medicine at the University of Nevada, 1701 West Charleston Boulevard - Suite 230, Las Vegas, NV 89102, USA. Electronic address: Katerinaromado@gmail.com.
² Internal Medicine, Kirk Kerkorian School of Medicine at the University of Nevada, 1701 West Charleston Boulevard - Suite 230, Las Vegas, NV 89102, USA.
³ Hepatitis B Foundation, Doylestown, PA, USA.
⁴ Medicine, Biostatistics, and Epidemiology, University of California San Francisco, San Francisco, CA, USA.

PMID: 37778782
DOI: 10.1016/j.cld.2023.05.009

Abstract

Hepatitis B infection affects approximately 262 million people worldwide and is responsible for 900,000 deaths annually. This article reviews the major factors limiting HBV elimination, which includes limited linkage to care and complicated HBV testing and treatment guidelines. The article then provides solutions to these pressing issues.

Keywords: Emerging therapies; HBV treatment; Hepatitis B virus; Linkage to care; Triple panel testing.

Publication types

Review

MeSH terms

DNA
Hepatitis B virus / genetics
Hepatitis B* / diagnosis
Hepatitis B* / prevention & control
Hepatitis B, Chronic* / diagnosis
Hepatitis B, Chronic* / prevention & control
Humans
Vaccination

Substances

DNA